A1 Journal article (refereed)
Systemic blockade of ACVR2B ligands protects myocardium from acute ischemia-reperfusion injury (2019)
Magga, J., Vainio, L., Kilpiö, T., Hulmi, J., Taponen, S., Lin, R., Räsänen, M., Szabó, Z., Gao, E., Rahtu-Korpela, L., Alakoski, T., Ulvila, J., Laitinen, M., Pasternack, A., Koch, W. J., Alitalo, K., Kivelä, R., Ritvos, O., & Kerkelä, R. (2019). Systemic blockade of ACVR2B ligands protects myocardium from acute ischemia-reperfusion injury. Molecular Therapy, 27(3), 600-610. https://doi.org/10.1016/j.ymthe.2019.01.013
JYU authors or editors
Publication details
All authors or editors: Magga, Johanna; Vainio, Laura; Kilpiö, Teemu; Hulmi, Juha; Taponen, Saija; Lin, Ruizhu; Räsänen, Markus; Szabó, Zoltán; Gao, Erhe; Rahtu-Korpela, Lea; et al.
Journal or series: Molecular Therapy
ISSN: 1525-0016
eISSN: 1525-0024
Publication year: 2019
Volume: 27
Issue number: 3
Pages range: 600-610
Publisher: Cell Press
Publication country: United Kingdom
Publication language: English
DOI: https://doi.org/10.1016/j.ymthe.2019.01.013
Publication open access: Openly available
Publication channel open access: Partially open access channel
Publication is parallel published (JYX): https://jyx.jyu.fi/handle/123456789/63160
Keywords: muscles; muscle cells; heart; proteins; growth factors; ischemia
Free keywords: activins; growth differentiation factors; ischemia-reperfusion injury
Contributing organizations
Related projects
- Riittävä lihasmassa ja aerobinen kunto eliniän pidentäjinä lihaskadossa
- Hulmi, Juha
- Research Council of Finland
Ministry reporting: Yes
Reporting Year: 2019
JUFO rating: 2